Skip to main content
Premium Trial:

Request an Annual Quote

Products & Services: Dec 10, 2009

Premium

Bioo Scientific has introduced the T3 Conjugation Kit for targeted in vivo delivery of siRNAs or other RNAi agents.

The T3 technology involves a carrier to an antibody that is specific to a receptor or other extracellular domain specific to the targeted cell or tissue type. The conjugate can then be loaded with an RNAi molecule.

According to the company, the kit can also be used for the in vitro delivery of siRNAs in primary cells or cell lines with mixed populations.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.